Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report) shares fell 0.9% during mid-day trading on Friday . The stock traded as low as $10.79 and last traded at $10.7960. Drugs Made in America Acquisition Price PerformanceThe firm has a 50-day moving average of $10.86 and a 200-day moving average of $10.67. Get Drugs Made in America Acquisition alerts:About Drugs Made in America Acquisition(Get Free Report)Drugs Made in America Acquisition Corp is a special purpose acquisition company incorporated in Delaware and traded on the NASDAQ under the ticker DMAAU. Further ReadingReceive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.